SCHEMBL2364146

SCHEMBL2364146

Cc1ccc(S(=O)(=O)O)cc1CC1COCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.41
ALDH1A1 P00352 4/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM3 P20309 1/20 0.36
ATM Q13315 1/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
ALOX12 P18054 1/20 0.35
PSEN1 P49768 2/20 0.34
PSEN2 P49810 2/20 0.34
APH1B Q8WW43 2/20 0.34
NCSTN Q92542 2/20 0.34
APH1A Q96BI3 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5153698 0.89 CA1 (0.34) ALDH1A1MAPTATMHSD17B10MAPK1
SCHEMBL537493 0.89 KMT2A (0.38) ALDH1A1MAPTHSD17B10CA12CA1
SCHEMBL3673653 0.89 KMT2A (0.38) ALDH1A1MAPTHSD17B10CA12CA1
SCHEMBL2484470 0.83 ATM (0.45) ALDH1A1SMN1; SMN2ATMKDM4EALOX12
SCHEMBL2484523 0.82 PIK3CD (0.36) ALDH1A1HCRTR1HCRTR2CYP3A4
SCHEMBL26641101 0.81 SNCA (0.36) ALDH1A1MAPTHSD17B10HCRTR1HCRTR2
SCHEMBL20184269 0.78 ALDH1A1 (0.44) USP2ALDH1A1L3MBTL1MAPTTHRB
SCHEMBL27216045 0.76 CA1 (0.34) ALDH1A1MAPTCA12CA1CA2
SCHEMBL20522658 0.76 USP2 (0.35) USP2ALDH1A1L3MBTL1MAPTSMN1; SMN2
SCHEMBL1888652 0.75 CA2 (0.39) ALDH1A1MAPTSMN1; SMN2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652184-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE AbbVie Inc. (US) 2020-05-20 EP disclosed
WO-2019035911-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC. (US) 2019-02-21 WO disclosed
EP-2350090-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2011-08-03 EP disclosed
WO-2010045251-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS, INC. (CA) 2010-04-22 WO disclosed